-
Innovation Through Collaboration: How Precision Biologic is Reshaping Hemostasis Diagnostics
A New Era in Hemostasis In the specialized world of blood coagulation, Precision Biologic is proving that collaborative innovation is the key to advancement. By bridging the gap between research and clinical diagnostics, the company has established itself as a pivotal player in the hemostasis industry. The Power of Partnership At the heart of Precision…
-
A Significant Step Forward: First U.S. Patient Enrolled in BiPASS Phase 3 Study for Prostate Cancer Diagnosis
NASDAQ: $TLX Today marks an important milestone in the ongoing effort to improve the diagnosis and management of prostate cancer. We are excited to share news regarding the initiation of dosing for the first U.S. patient in the pivotal BiPASS Phase 3 clinical trial. This study focuses on assessing the performance of a novel diagnostic…